Market Intelligence
Your pre-interview briefing room. Know what every other candidate doesn't.
Last updated: March 18, 2025
Weekly Briefing
This Week in Banking
Updated March 18, 2025
Fed held rates steady at 5.25–5.50% but signaled two cuts remain possible in 2025, keeping leveraged finance markets cautiously optimistic.
M&A volumes are running ~18% above 2024 pace YTD, led by technology and healthcare consolidation as strategic buyers return to the table.
Investment-grade spreads tightened to 95bps over Treasuries, the tightest since 2021, reflecting strong demand for quality corporate paper.
Three IPOs priced above range this week including a $2.1B fintech offering, signaling the IPO window is firmly open heading into Q2.
Apollo and Blackstone collectively deployed $14B in new LBO and credit investments in Q1, the most active sponsor quarter since 2022.
RECENT TRANSACTIONS
Notable Deals This Week
March 18, 2025
Synopsys / Ansys
$35BM&A
EDA software consolidation play; Synopsys acquiring simulation leader to create end-to-end chip design platform ahead of AI-driven semiconductor complexity.
Capital One / Discover Financial
$35.3BM&A
Transformative bank merger creating the largest U.S. credit card company by loan volume; pending regulatory approval has defined the financial services M&A narrative for 18 months.
Johnson & Johnson / Shockwave Medical
$13.1BM&A
J&J expanding cardiovascular portfolio; Shockwave's intravascular lithotripsy technology addresses a $3B+ addressable market in coronary artery disease.
ServiceTitan IPO
$2.0BIPO
Home services software platform priced at $71/share, above the $65–68 range; strong debut validates SaaS valuations for vertical market software in a recovering IPO market.
Blackstone Credit / AIR Communities
$10BLBO
Blackstone taking apartment REIT private at a 25% premium; deal reflects sponsor conviction in multifamily fundamentals despite high financing costs.
Macro Snapshot
March 18, 2025
Fed held rates at 5.25–5.50% at the March meeting; two cuts still projected for 2025 but data-dependent.
10-year Treasury yield at 4.28%, down 18bps month-over-month as inflation continues its gradual decline.
CPI came in at 3.1% YoY in February; core PCE running at 2.8%, still above the 2% target.
GDP growth tracking 2.1% annualized in Q1 2025, below the 2.5% consensus estimate.
Dollar index (DXY) at 104.2; strong dollar creating headwinds for multinationals reporting Q1 earnings.
INTERVIEW ANGLE
When asked about the macro environment, lead with the Fed's rate path and its direct impact on deal activity — "With rates holding at 5.25–5.50% and two cuts potentially on the horizon, we're seeing sponsors manage deal timing carefully around refinancing windows." Connect the 10-year yield to valuation multiples: higher for longer means continued DCF compression on long-duration growth assets, which is why strategic M&A by cash-rich corporates is outpacing financial sponsor activity right now.
Credit Markets
March 18, 2025
Investment-grade spreads at 95bps over Treasuries, tightest level since October 2021.
High-yield spreads at 310bps, well inside the 400bps+ distress threshold; market is pricing benign credit conditions.
Leveraged loan market seeing strong CLO demand; new CLO formation up 35% YoY in Q1 2025.
$45B in IG issuance priced in the past two weeks as corporates front-run any rate volatility.
SOFR-based floating rate debt now preferred structure for new LBO financings following LIBOR transition completion.
INTERVIEW ANGLE
Credit market conditions are directly relevant to your LBO and M&A deal work. IG spreads at 95bps means acquisition financing for investment-grade acquirers is historically cheap — frame this as a tailwind for strategic M&A. For HY/leveraged finance questions, the 310bps spread signals lenders are willing to underwrite deals, which is why sponsor activity is picking up. A strong answer connects current spread levels to deal structuring decisions.
M&A Environment
March 18, 2025
Global M&A volume at $892B in Q1 2025, up 18% vs. Q1 2024 and the strongest first quarter since 2022.
Technology sector leading deal activity at $218B, driven by AI infrastructure acquisitions and software consolidation.
Healthcare M&A at $134B YTD; large pharma actively acquiring biotech assets ahead of patent cliff.
Cross-border deal activity recovering; European buyers acquiring U.S. assets at a 12-year high pace.
Average deal premiums running at 28% over 30-day VWAP, up from 22% in 2024, reflecting competitive auction processes.
INTERVIEW ANGLE
M&A activity questions are your opportunity to demonstrate market awareness. Lead with the 18% YoY volume increase and attribute it to specific drivers: strategic buyers with strong balance sheets, compressed equity valuations in certain sectors making targets more attractive, and the AI infrastructure buildout creating must-have acquisition targets in tech. If asked about deal premiums, the 28% average is a useful anchor — explain why competitive processes and limited quality assets are keeping prices elevated despite higher financing costs.
Sector Spotlight
March 18, 2025
Technology: AI infrastructure spend driving data center M&A; hyperscaler capex guidance up 40% YoY, creating tailwinds for semiconductor and networking deals.
Healthcare: Biotech valuations recovering after 2022-2023 bear market; large-cap pharma M&A replacing declining organic R&D pipelines.
Energy: Permian Basin consolidation wave continuing; upstream M&A at $120B in past 12 months as majors build scale.
Financial Services: Regional bank consolidation accelerating post-SVB; 12 bank mergers announced YTD vs. 8 in full-year 2024.
Consumer: Discretionary spending bifurcating; luxury resilient, mid-market struggling; activism driving portfolio simplification.
INTERVIEW ANGLE
Sector knowledge signals genuine market engagement to interviewers. Pick one or two sectors most relevant to the group you're interviewing with and go deeper. For tech groups, the AI infrastructure buildout and hyperscaler capex is your anchor — "Companies that provide picks-and-shovels for AI compute are commanding strategic premiums." For healthcare, connect the biotech acquisition wave to the patent cliff math: large pharma loses $200B+ in revenues by 2030, making acquisitions economically necessary at almost any price.
ECM & IPO Watch
March 18, 2025
IPO market firmly open: 23 IPOs priced in Q1 2025 raising $18.4B, vs. 11 deals raising $6.2B in Q1 2024.
Average IPO first-day return of 14% in Q1; aftermarket performance strong, reducing institutional hesitancy.
S&P 500 at 5,218; forward P/E of 20.4x — valuation constructive for new issuance but not euphoric.
Convertible bond issuance surging: $28B YTD as companies exploit low implied volatility to issue cheap convert paper.
Follow-on market equally active: 67 secondary offerings YTD vs. 41 in same period 2024; sponsors using window to exit positions.
INTERVIEW ANGLE
ECM market conditions are a window into overall risk appetite. The IPO window reopening after a two-year drought is significant — frame it as a function of multiple factors converging: equity market stability, improved growth outlooks, and institutional investors needing new paper after sitting on cash. For convertible bond questions, explain the mechanics: low vol = cheap embedded call options = lower coupon for issuers. Strong aftermarket performance is the most important leading indicator for whether the IPO window stays open.
DISTRESSED
Restructuring & Distressed Watch
March 18, 2025
Consumer discretionary and commercial real estate remain the highest-stress sectors; office CRE delinquency rates at 8.2%, highest since 2012.
Pluralsight filed Chapter 11 this quarter; PE-backed tech education company citing post-pandemic demand normalization and $1.4B debt burden.
Covenant-lite loan structures limiting near-term default triggers but pushing distress into 2025-2026 maturity wall.
$215B in leveraged loans maturing in 2025-2026; refinancing risk elevated for issuers with weak EBITDA growth.
Restructuring advisory mandates up 34% YoY at bulge bracket firms; Lazard and PJT reporting strongest restructuring pipelines since 2020.
INTERVIEW ANGLE
Restructuring knowledge differentiates candidates who understand the full deal lifecycle. Lead with the maturity wall concept — $215B in loans maturing creates refinancing stress for companies that can't grow into their leverage multiples. If asked about distressed opportunities, frame it as a barbell: companies that can refinance will, but those with genuine business deterioration will need balance sheet restructuring. The office CRE situation is a great specific example: rising vacancies + floating rate debt + falling valuations = textbook distressed scenario.
ECM PIPELINE
IPO & New Issuance Pipeline
March 18, 2025
IPO window open and constructive; market volatility (VIX at 14.2) providing stable backdrop for new issuance.
Notable upcoming IPOs: Klarna (fintech, ~$15-20B valuation), Cerebras Systems (AI chips, ~$7B), StubHub (ticketing, ~$16B).
Recent pricings: ServiceTitan ($2B, above range), Astera Labs ($8.1B market cap at open, +72% first day).
SPAC activity remains subdued at ~3-4 new blank check companies per month vs. peak of 100+/month in 2021.
De-SPAC transactions creating overhang; 60+ SPAC combinations from 2020-2022 now trading below trust value.
INTERVIEW ANGLE
IPO pipeline questions test your ability to connect market conditions to new issuance decisions. The key framework: companies IPO when they can, not when they must — so an open window reflects positive equity sentiment, institutional demand for growth assets, and founder/sponsor desire for liquidity. Klarna's expected IPO is a useful case study: delayed from 2022 peak valuation of $46B, now targeting $15-20B, illustrating how companies wait for valuation recovery before accessing public markets. The SPAC comparison shows how market structures shift with capital availability.
PRIVATE EQUITY
PE & Sponsor Activity
March 18, 2025
Apollo, Blackstone, and KKR collectively deployed $42B in new investments in Q1 2025, most active quarter since 2022.
LBO financing markets reopening: average new LBO leverage at 5.8x EBITDA, up from 5.1x trough in Q3 2023.
Notable LBOs: Blackstone / Hippo Insurance ($1.5B), Apollo / ADT commercial security division ($1.8B).
PE exits accelerating: 47 sponsor-backed IPOs and M&A exits in Q1 2025 vs. 29 in Q1 2024 as GPs seek liquidity.
Fundraising environment challenging: mega-funds closing on target but mid-market managers facing LP fatigue after compressed distributions 2022-2023.
INTERVIEW ANGLE
PE and sponsor activity is directly relevant for any leveraged finance or M&A interview. Frame the sponsor recovery as a financing story: as leveraged loan and HY markets reopened and rates stabilized, deal economics started working again at 5.8x leverage. For exit activity questions, note that GPs have $3.2 trillion in unrealized portfolio value globally — the pressure to return capital to LPs is creating a multi-year exit supercycle. If asked about specific sponsors, Apollo and Blackstone's $42B deployment shows conviction that asset values have bottomed.
How to use this in interviews
When an interviewer asks “what's your view on the M&A environment?” or “walk me through what you're seeing in markets” — don't just recite frameworks. Lead with a specific data point, connect it to deal activity, and close with an implication. Example: “Leveraged loan spreads have widened meaningfully, which has compressed the LBO universe — sponsors are being more selective, and we're seeing more strategic deal flow as a result.” That answer gets remembered.